Detalhe da pesquisa
1.
PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase.
Am J Hematol
; 90(1): 20-6, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25250944
2.
Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib.
Blood
; 120(2): 291-4, 2012 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22645182
3.
A common novel splice variant of SLC22A1 (OCT1) is associated with impaired responses to imatinib in patients with chronic myeloid leukaemia.
Br J Haematol
; 163(5): 631-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24117365
4.
Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia.
Blood
; 120(3): 697-8, 2012 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22822001
5.
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in nonimmune pediatric travelers: results of an international, randomized, open-label study.
Clin Infect Dis
; 38(12): 1716-23, 2004 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15227617